Vaxcyte Inks Up to $1b Deal for Fill-Finish at Thermo Fisher's N.c. Facility
Posted3 months agoActive3 months ago
fiercepharma.comOtherstory
calmpositive
Debate
0/100
BiotechPharmaceutical ManufacturingPartnerships
Key topics
Biotech
Pharmaceutical Manufacturing
Partnerships
Vaxcyte has signed a deal with Thermo Fisher worth up to $1B for fill-finish manufacturing at Thermo Fisher's North Carolina facility, indicating a significant partnership in the biotech industry.
Snapshot generated from the HN discussion
Discussion Activity
Light discussionFirst comment
7m
Peak period
1
0-1h
Avg / period
1
Key moments
- 01Story posted
Oct 3, 2025 at 11:06 AM EDT
3 months ago
Step 01 - 02First comment
Oct 3, 2025 at 11:12 AM EDT
7m after posting
Step 02 - 03Peak activity
1 comments in 0-1h
Hottest window of the conversation
Step 03 - 04Latest activity
Oct 3, 2025 at 11:12 AM EDT
3 months ago
Step 04
Generating AI Summary...
Analyzing up to 500 comments to identify key contributors and discussion patterns
ID: 45463824Type: storyLast synced: 11/17/2025, 12:11:59 PM
Want the full context?
Jump to the original sources
Read the primary article or dive into the live Hacker News thread when you're ready.
Part of the "onshoring" trend moving more manufacturing to US facilities, probably due to both pandemic response and the current political climate. Overall imo CDMOs are holding more power in this biotech climate.